Apnicaf Oral Solution
By Apnicaf
Rx
1ml Oral Solution in a Bottle

Composition
Caffeine(10mg)

Manufacturer - Abbott
16th Floor, Godrej BKC, Plot – C, "G" Block, Bandra-Kurla Complex, Bandra (East), Mumbai – 400 051, India

Expires on or after
October, 2025

liver
For individuals with liver disease, limited information is currently available regarding the use of Apnicaf Oral Solution. It is advisable to consult with your doctor before considering the use of this product to ensure its safety and suitability for your specific condition.

kidney
Limited information exists on using Apnicaf Oral Solution in patients with kidney disease. Consult your doctor for guidance.

alcohol
It is not safe to drink alcohol while using Apnicaf Oral Solution. Be cautious about this when pregnant.

driving
When taking Apnicaf Oral Solution, be cautious while driving as it can reduce alertness, cause vision issues, and lead to drowsiness and dizziness. Avoid driving if you experience these effects.

pregnancy
Apnicaf Oral Solution may not be safe during pregnancy. Animal studies suggest potential harm to the baby. Consult with your doctor for a thorough evaluation of risks versus benefits before use.

breastfeeding
It is important to use Apnicaf Oral Solution with caution while breastfeeding. Wait until the mother has finished treatment and the drug is no longer in her system before breastfeeding.
Habit Forming | No |
Chemical Class | Xanthine Derivative |
Therapeutic Class | - |
Action Class | Adenosine receptor (A1 & A2) antagonist |
₹280.54
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025